BLEEFIX Trademark

Trademark Overview

On Monday, December 6, 2021, a trademark application was filed for BLEEFIX with the United States Patent and Trademark Office. The USPTO has given the BLEEFIX trademark a serial number of 79331108. The federal status of this trademark filing is REGISTERED as of Tuesday, October 24, 2023. This trademark is owned by HLB CELL CO., LTD. The BLEEFIX trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes for hemostasis; veterinary preparations for hemostasis; pharmaceuticals for hemostasis; pharmaceutical compositions for hemostasis; drugs for medical purposes for hemostasis; pharmaceutical drugs for hemostasis; therapeutic drugs and agents for hemostasis; pharmaceutical preparations for wounds; styptic pencils; haemostatic preparations; hemostatics for medical purposes; hemostatic agents for surgical use; topical hemostatic agents for use in surgery; bioabsorbable hemostatic agents; powder type hemostatic agent; medical and surgical plasters; dissolvable strips to stop bleeding from minor cuts and grazes; wound dressings; medical adhesives for binding wounds
bleefix

General Information

Serial Number79331108
Word MarkBLEEFIX
Filing DateMonday, December 6, 2021
Status700 - REGISTERED
Status DateTuesday, October 24, 2023
Registration Number7198022
Registration DateTuesday, October 24, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 9, 2023

Trademark Statements

Goods and ServicesMedicines for human purposes for hemostasis; veterinary preparations for hemostasis; pharmaceuticals for hemostasis; pharmaceutical compositions for hemostasis; drugs for medical purposes for hemostasis; pharmaceutical drugs for hemostasis; therapeutic drugs and agents for hemostasis; pharmaceutical preparations for wounds; styptic pencils; haemostatic preparations; hemostatics for medical purposes; hemostatic agents for surgical use; topical hemostatic agents for use in surgery; bioabsorbable hemostatic agents; powder type hemostatic agent; medical and surgical plasters; dissolvable strips to stop bleeding from minor cuts and grazes; wound dressings; medical adhesives for binding wounds

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHLB CELL CO., LTD
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressKR
Party NameHLB CELL CO., LTD
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressKR
Party NameHLB CELL CO., LTD
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKR

Trademark Events

Event DateEvent Description
Monday, February 19, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, January 25, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 25, 2024FINAL DISPOSITION PROCESSED
Wednesday, January 24, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 24, 2023REGISTERED-PRINCIPAL REGISTER
Sunday, September 17, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, July 3, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, June 14, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, June 1, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, May 10, 2023NOTIFICATION PROCESSED BY IB
Tuesday, May 9, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2023PUBLISHED FOR OPPOSITION
Wednesday, April 19, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 19, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 15, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 15, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 28, 2022REFUSAL PROCESSED BY IB
Tuesday, December 6, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 6, 2022REFUSAL PROCESSED BY MPU
Friday, September 23, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 22, 2022NON-FINAL ACTION WRITTEN
Wednesday, September 14, 2022ASSIGNED TO EXAMINER
Tuesday, January 18, 2022APPLICATION FILING RECEIPT MAILED
Friday, January 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 13, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

bleefix hemostasis medical agents hemostatic pharmaceutical drugs purposes preparations wounds surgical